Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.
Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, Selemon A, Whelan M, Premji Z, Issa H, Cheng B, Abu Raddad LJ, Buckeridge DL, Van Kerkhove MD, Piechotta V, Higdon MM, Wilder-Smith A, Bergeri I, Feikin DR, Arora RK, Patel MK, Subissi L. Bobrovitz N, et al. Among authors: bergeri i. Lancet Infect Dis. 2023 May;23(5):556-567. doi: 10.1016/S1473-3099(22)00801-5. Epub 2023 Jan 18. Lancet Infect Dis. 2023. PMID: 36681084 Free PMC article.
Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.
Public Health Collaborators on Serosurveillance for Pandemic Preparedness and Response PHSeroPPR. Public Health Collaborators on Serosurveillance for Pandemic Preparedness and Response PHSeroPPR. Lancet. 2023 Jul 29;402(10399):356-358. doi: 10.1016/S0140-6736(23)00964-9. Epub 2023 May 26. Lancet. 2023. PMID: 37247625 Free PMC article. No abstract available.
Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January-December 2020.
Vaughan A, Duffell E, Freidl GS, Lemos DS, Nardone A, Valenciano M, Subissi L, Bergeri I, K Broberg E, Penttinen P, Pebody R, Keramarou M. Vaughan A, et al. Among authors: bergeri i. BMJ Open. 2023 Nov 6;13(11):e064240. doi: 10.1136/bmjopen-2022-064240. BMJ Open. 2023. PMID: 37931969 Free PMC article.
SARS-CoV-2 seroepidemiology in Mongolia, 2020-2021: a longitudinal national study.
Chimeddorj B, Bailie CR, Mandakh U, Price DJ, Bayartsogt B, Meagher N, Altanbayar O, Magvan B, Deleg Z, Gantumur A, Byambaa O, Nyamdavaa E, Enkhtugs K, Munkhbayar U, Bayanjargal B, Badamsambuu T, Dashtseren M, Amartuvshin T, Narmandakh Z, Togoo K, Boldbaatar EA, Bat-Erdene A, Chimeddorj U, Nyamdavaa K, Tsevegmid E, Batjargal O, Enebish O, Enebish G, Batchuluun B, Zulmunkh G, Byambatsogt G, Enebish T, Le LV, Bergeri I, McVernon J, Erkhembayar R. Chimeddorj B, et al. Among authors: bergeri i. Lancet Reg Health West Pac. 2023 Apr 10;36:100760. doi: 10.1016/j.lanwpc.2023.100760. Online ahead of print. Lancet Reg Health West Pac. 2023. PMID: 37360871 Free PMC article.
Adherence of SARS-CoV-2 Seroepidemiologic Studies to the ROSES-S Reporting Guideline During the COVID-19 Pandemic.
Cheng B, Loeschnik E, Selemon A, Hosseini R, Yuan J, Ware H, Ma X, Cao C, Bergeri I, Subissi L, Lewis HC, Williamson T, Ronksley P, Arora RK, Whelan M, Bobrovitz N. Cheng B, et al. Among authors: bergeri i. Influenza Other Respir Viruses. 2024 Jul;18(7):e13283. doi: 10.1111/irv.13283. Influenza Other Respir Viruses. 2024. PMID: 39053893 Free PMC article. Review.
WHO's Investigations and Studies, Unity Studies: A global initiative creating equitable opportunities for enhanced surveillance, operational research, capacity building, and global knowledge sharing.
Bergeri I, Boddington NL, Lewis HC, Subissi L, von Dobschuetz S, Rodriguez A, Jara J, El Naja HA, Barakat A, Rashidian A, Aly EA, Al Ariqi L, Wijesinghe P, Inbanathan F, Nguyen PN, Phengxay M, Le LV, Enebish T, Okeibunor J, Herring B, Farley E, Jorgensen P, Vaughan AM, Mott J, Zhang W, Pebody R, Van Kerkhove MD. Bergeri I, et al. Influenza Other Respir Viruses. 2024 Feb;18(2):e13256. doi: 10.1111/irv.13256. Influenza Other Respir Viruses. 2024. PMID: 38346794 Free PMC article.
Short communication-Lessons learnt during the implementation of Unity-aligned SARS-CoV-2 seroprevalence studies in Africa.
Farley E, Okeibunor J, Balde T, Donkor IO, Kleynhans J, Wamala JF, Kaboré NF, Balam S, Chamla D, Braka F, Subissi L, Herring B, Whelan MG, Bergeri I, Lewis HC. Farley E, et al. Among authors: bergeri i. Influenza Other Respir Viruses. 2023 Aug 23;17(8):e13170. doi: 10.1111/irv.13170. eCollection 2023 Aug. Influenza Other Respir Viruses. 2023. PMID: 37621920 Free PMC article.
Evolution of seroprevalence to SARS-CoV-2 in blood donors in Sarajevo Canton, Federation of Bosnia and Herzegovina: Cross-sectional and longitudinal studies.
Musa S, Catovic Baralija E, Ivey Sawin V, Nardone A, Palo M, Skocibusic S, Blazevic M, Cilovic Lagarija S, Ahmetovic-Karic G, Ljuca A, Dostovic-Halilovic S, Nedic R, Subissi L, Ibrahim R, Boshevska G, Bergeri I, Pebody R, Vaughan A. Musa S, et al. Among authors: bergeri i. Influenza Other Respir Viruses. 2023 Aug 22;17(8):e13182. doi: 10.1111/irv.13182. eCollection 2023 Aug. Influenza Other Respir Viruses. 2023. PMID: 37621919 Free PMC article.
Household transmission investigation: Design, reporting and critical appraisal.
Price DJ, Spirkoska V, Marcato AJ, Meagher N, Fielding JE, Karahalios A, Bergeri I, Lewis H, Valenciano M, Pebody R, McVernon J, Villanueva-Cabezas JP. Price DJ, et al. Among authors: bergeri i. Influenza Other Respir Viruses. 2023 Jun 15;17(6):e13165. doi: 10.1111/irv.13165. eCollection 2023 Jun. Influenza Other Respir Viruses. 2023. PMID: 37333946 Free PMC article.
42 results